Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan

American Journal of Public Health

Volumn 93, Issue 3, 2003, Pages 489-492

  Chen, Kow Tong ^a   Twu, Shiing Jer ^a   Chang, Hong Jen ^b   Lin, Ruey Shiung ^c  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b Department of Health ^*  (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MEBENDAZOLE; METRONIDAZOLE;

ADULT; AMEBIASIS; ARTICLE; DYSENTERY; EPIDEMIC; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTOZOAL INFECTION; RACE DIFFERENCE; RISK FACTOR; STEVENS JOHNSON SYNDROME; TAIWAN; TOXIC EPIDERMAL NECROLYSIS;

EID: 0037372395     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.93.3.489     Document Type: Article

References (17)

1. Chean HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a populationbased study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990;126:43-47.
2. Fritsch PO, Ruiz-Maldonado R. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill Book Co; 1999:636-654.
3. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956;68:355-361.
4. Tyson R, Walker J. An unusual bullous eruption. S Afr Med J. 1956;30:97-98.
5. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92-96.
6. Hemborg A. Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique. Lancet. 1985;2(8463):1072-1073.
7. Egan CA, Grant WJ, Morris SE, Saffle JR, Zone JJ. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol. 1999;40:458-461.
8. Public Health in Taiwan. Taiwan, Republic of China: Taiwan Dept of Health; 1998.
9. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1607.
10. Chan HL. Observation on drug-induced toxic epidermal necrolysis in Singapore. J Am Acad Dermatol. 1984;10:973-978.
11. Snyder RA, Elias PM. Toxic epidermal necrolysis and staphylococcal scalded skin syndrome. Dermatol Clin. 1983;1:235-238.
12. Yetiv JZ, Bianchine JR, Owen JA Jr. Etiologic factors of the Stevens-Johnson syndrome. South Med J. 1980;73:599-602.
13. Roujeau JC, Stern RS. Severe adverse cutaneous reaction to -drugs. N Engl J Med. 1994;331:1272-1285.
14. House RA, Jakubovic H, Wong L, Holness DL. Work-related toxic epidermal necrolysis? J Occup Med. 1992;34:135-139.
15. Nethercott JR, Choi BC. Erythema multiforme (Stevens-Johnson syndrome)-chart review of 123 hospitalized patients. Dermatologia. 1985;171:383-396.
16. Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol. 1987;123:1171-1173.
17. Stacy AW, Widaman KF, Hays R, DiMatteo MR. Validity of self-reports of alcohol and other drug use: a multitrait-multimethod assessment. J Pers Soc Psychol. 1985;49:219-232.